AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: CBUS
Report Date: 2026-04-07
Full Report: https://amaly.io/stock/CBUS

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: CBUS, a biotechnology company in an unknown sector per available profiles, faces Shariah compliance challenges primarily from elevated debt and liquidity ratios exceeding key thresholds in major screening standards. While non-permissible income remains negligible and core business activities in gene editing and sustainable agriculture align with Islamic principles, financial metrics lead to exclusion from Shariah indices. Purification is required for incidental interest income, estimated at 4.21% of revenue. Investors are advised to monitor debt reduction initiatives for potential compliance improvements.

Primary Compliance Concerns:
- debtRatio: 48.11% (threshold: 30%)
- liquidityRatio: 31.83% (threshold: 30%)

Purification Requirement: 4.21%
Index Inclusion: Not included in any major Shariah indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 48.1%
Liquidity Ratio: 31.8%
Interest Income Ratio: 4.2%
Purification Required: 4.21%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-11-30

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-20T12:00:00Z

---
Full interactive report: https://amaly.io/stock/CBUS
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.